Brokerages Set Option Care Health, Inc. (NASDAQ:OPCH) Price Target at $29.92

Shares of Option Care Health, Inc. (NASDAQ:OPCH) have earned an average rating of “Moderate Buy” from the fourteen analysts that are covering the firm, Marketbeat reports. Seven investment analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $29.9231.

Several research firms recently weighed in on OPCH. Wall Street Zen upgraded Option Care Health from a “hold” rating to a “buy” rating in a research note on Saturday, August 1st. Truist Financial set a $30.00 price objective on shares of Option Care Health in a report on Friday, May 1st. UBS Group reissued a “buy” rating on shares of Option Care Health in a report on Tuesday, June 16th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $24.00 price target (down from $26.00) on shares of Option Care Health in a research report on Thursday, July 30th. Finally, Weiss Ratings raised Option Care Health from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Tuesday, August 11th.

Option Care Health Trading Up 0.2%

Option Care Health stock opened at $23.41 on Friday. The firm’s fifty day moving average price is $22.21 and its 200-day moving average price is $25.74. Option Care Health has a fifty-two week low of $18.01 and a fifty-two week high of $36.80. The stock has a market cap of $3.51 billion, a P/E ratio of 17.60, a PEG ratio of 1.39 and a beta of 0.65. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.98 and a current ratio of 1.47.

Option Care Health (NASDAQ:OPCH) last announced its earnings results on Wednesday, July 29th. The company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.02. Option Care Health had a net margin of 3.68% and a return on equity of 18.74%. The business had revenue of $1.44 billion during the quarter, compared to analyst estimates of $1.42 billion. During the same period in the previous year, the business posted $0.41 earnings per share. Option Care Health’s revenue for the quarter was up 1.9% on a year-over-year basis. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. Equities research analysts forecast that Option Care Health will post 1.69 earnings per share for the current fiscal year.

Institutional Trading of Option Care Health

Several hedge funds have recently made changes to their positions in OPCH. Cornerstone Investment Partners LLC raised its position in shares of Option Care Health by 3.4% during the 4th quarter. Cornerstone Investment Partners LLC now owns 9,773 shares of the company’s stock valued at $311,000 after buying an additional 318 shares during the period. UMB Bank n.a. grew its position in Option Care Health by 23.5% in the fourth quarter. UMB Bank n.a. now owns 1,715 shares of the company’s stock worth $55,000 after acquiring an additional 326 shares during the period. Fifth Third Bancorp grew its position in Option Care Health by 21.9% in the fourth quarter. Fifth Third Bancorp now owns 2,328 shares of the company’s stock worth $74,000 after acquiring an additional 419 shares during the period. Andina Capital Management LLC lifted its stake in shares of Option Care Health by 2.6% in the 4th quarter. Andina Capital Management LLC now owns 16,320 shares of the company’s stock valued at $520,000 after purchasing an additional 419 shares during the last quarter. Finally, ProShare Advisors LLC lifted its stake in shares of Option Care Health by 1.3% in the 4th quarter. ProShare Advisors LLC now owns 35,533 shares of the company’s stock valued at $1,132,000 after purchasing an additional 444 shares during the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.